Siemens Aktiengesellschaft · XETR:SIE
Siemens Aktiengesellschaft — Siemens — Investor Day (February 2012)
30 slides from Siemens Aktiengesellschaft's investor day presentation, Feb 14, 2012
Slide 1: Imaging & Therapy Systems – Leading the imaging industry
Imaging & Therapy Systems – Leading the imaging industry Bernd Montag CEO Healthcare Imaging & Therapy Systems Capital Market Day Siemens Healthcare London, February 14, 2012 © Siemens AG 2012. All rights reserved.
Slide 2: Safe Harbour Statement
Safe Harbour Statement This document contains forward-looking statements and information – that is, statements related to future, not past, events. These statements may be identified by words such as ―expects,‖ ―looks forward to,‖ ―anticipates,‖ ―intends,‖ ―plans,‖ ―believes,‖ ―seeks,‖ ―estimates,‖
Slide 3: Images, leading the way
Images, leading the way Directing care – With initial diagnosis and during treatment Stent placed correctly? Bone fracture fixated? Surgery or Chemotherapy? © Siemens AG 2012. All rights reserved. Page 3 February 14, 2012 Capital Market Day Healthcare Healthcare Imaging & Therapy Systems
Slide 4: Leading the imaging industry: #1 in all modalities
Leading the imaging industry #1 in all modalities #1 #1 SYNGO Angio & Interventional X-Ray Advanced Computed Tomography Visualization Magnetic Resonance Molecular Imaging #1 #1 #1 © Siemens AG 2012. All rights reserved. Page 4 February 14, 2012 Capital Market Day Healthcare Healthcare Imaging & Ther
Slide 5: Partner of choice in all segments, e.g. academic research
Leading the imaging industry Partner of choice in all segments, e.g. in academic research Johns Hopkins Hospital, Baltimore Most advanced imaging equipment Installed base comprises: 4 Siemens Angio X-Ray systems 7 Siemens CT scanners 1 Siemens PET/CT scanner 2 Siemens SPECT scanners 7 Siem
Slide 6: Partner of choice for buying groups and long term contracts
Leading the imaging industry Partner of choice for buying groups and long term contracts Evangelisches Krankenhaus Bielefeld, Germany MedQuest, U.S. Acibadem, Parkway Pantai Group, Turkey Singapore G4 project with Alliar, FY 2011 Alliar, 52 scanners in total Brazil - 30 MRI scanners - 14 CT scanne
Slide 7: Partner of choice for first time users in China
Leading the imaging industry Partner of choice for first time users in China First time access to MR / CT for >150 hospitals Focus on County Level Hospitals (CLH) FY 2011 Harbin Urumqi Shenyang Beijing Dalian Hebei Xining Tsinghua Jinan Zhengzhou Ma'anshan Targeted CT purchases (5 year plan) Anhui X
Slide 8: Trendsetter and undisputed innovation leader
Leading the imaging industry Trendsetter and undisputed innovation leader 2010: MR/PET Siemens unique 2009: Sub mSv Cardiac CT Siemens unique 2007: Robot guided Imaging in the OR Siemens unique 2005: Dual Source CT Siemens unique 2004:DynaCT: 3D Imaging in the treatment room 70 cm Siemens set the tr
Slide 9: Biograph mMR – THE new gold standard in imaging
Leading the imaging industry Biograph mMR – THE new gold standard in imaging First simultaneous MR / PET scanner Mobile Applications FDA press release ― Advantages of the Siemens Biograph mMR system over current systems include simultaneous imaging, reduced radiation dose, and increased soft ― tissu
Slide 10: syngo.via: #1 in advanced visualization
Leading the imaging industry syngo.via: #1 in advanced visualization MobileApplications Mobile applications Average time savings through syngo.via Enabled by syngo Cloud CT Vascular 27% CT Cardiac 77% CT Onco Follow-up 16% MR Onco 32% PET/CT Onco Diagnosis 45% PET/CT Onco Follow-up 30% Apple iPad Ap
Slide 11: Trendsetter and market leader in fast growing new segments
Leading the imaging industry Trendsetter and market leader in fast growing new segments Hybrid operating rooms Neurodegenerative diseases In room 3D imaging Molecular Imaging is extremely promising for enables minimally invasive diagnosing of Neurodegenerative diseases e.g. procedures Alzheimer'
Slide 12: Pioneering research in close collaborations with academia
Leading the imaging industry Pioneering research in close collaborations with academia The Human Connectome Project Primary institutions: University of California, Los Angeles Massachusetts General Hospital Washington University in St. Louis University of Minnesota Tuesday, Jan. 24, 2012 Pro
Slide 13: Market leader in developed and emerging markets
Leading the imaging industry Market leader in developed and emerging markets #1 position in #1 position in developed markets emerging markets #1 position in 37% 36% SEWEC 1) markets 39% Revenue 2) growth in emerging markets CAGR +33% CAGR CAGR CAGR +13% +15% +21% FY09 FY11 FY09 FY11 FY09 FY11 FY09 F
Slide 14: Unique integrated set-up
Leading the imaging industry Unique integrated set-up Network of more than 1,100 close Most balanced footprint cooperation's with opinion leaders Oxford Kemnath Erlangen / Forchheim Hoffman Estates Malvern Concord Knoxville Shanghai Shenzhen Bangalore #1 in developed Manufacturing markets Sourcing R
Slide 15: High returns
Why? Consistent long-term strategy 36% Global market share >50,000 Systems worldwide #1 in Market Share #1 in Installed Base #1 in Profitability High returns For both equipment and service © Siemens AG 2012. All rights reserved. Page 15 February 14, 2012 Capital Market Day Healthcare Healthcare Imag
Slide 16: The world becomes flat
The world becomes flat Converging needs and challenges worldwide World equipment market Similar disease burden worldwide RoW 1) Cardiovascular Respiratory diseases diseases FY U.S. 2006 Cancer Diabetes China Japan Germany Similar challenges for healthcare systems U.S. Healthcare costs Developed Guid
Slide 17: We are driving the shift in a changing market place
The world becomes flat We are driving the shift in a changing market place New Orders (Siemens) Units sold by segment (Siemens) 2) Entry-level High-end 12% RoW 1) FY U.S. Developed 41% 2006 markets 47% China Mid-range Japan Germany High-end U.S. 9% Entry-level FY RoW 1) Emerging 30% 2011 markets 61%
Slide 18: Growing presence and business responsibility in China
Agenda 2013: Neurodegenerative Growing presence and business responsibility in China Siemens sites in Shanghai and Shenzhen Shanghai Shenzhen PLM and SCM headcount in China Products from China: Example CT CAGR Product Mgmt, +11% Mid-range Perspective R&D, Production & Sourcing >1,500 R&D, Production
Slide 19: Powerful track-record of Siemens products from China
Powerful track-record of Siemens products from China … with more to come … Siemens unit sales per region FY 2011 BIC 2) RoW 1) RoW 1) BIC 2) MAGNETOM ESSENZA SOMATOM Spirit Best selling MRI in India Best selling CT in Brazil Every 4th MRI and every 2nd CT out of China Units manufactured in China FY
Slide 20: SOMATOM Perspective – Game changer in mid-range CT
High-throughput, cost-efficient products SOMATOM Perspective – Game changer in mid-range CT Integrated global set-up SOMATOM Perspective 128-slice CT Forchheim Shanghai: Product Ownership Globally optimized R&D and manufacturing Focus on cost-reduction Customer benefits CoGS 1) Costs per treatment
Slide 21: Introducing the new MAGNETOM Spectra
Introducing the new MAGNETOM Spectra 3 Tesla premium quality MRI – Now made widely accessible MAGNETOM Spectra It's the key to 3T! © Siemens AG 2012. All rights reserved. Page 21 February 14, 2012 Capital Market Day Healthcare Healthcare Imaging & Therapy Systems
Slide 22: Strong demand for 3T MRI but high pressure on costs
Introducing the new MAGNETOM Spectra Strong demand for 3T MRI but high pressure on costs 3T MRI: Growing global demand 3T MRI: New standard in clinical routine1) Research Clinical > 500 units 2000 2002 2004 2006 2008 2010 2005 2007 2009 2011 Pressure on reimbursement Growing importance of emerging m
Slide 23: Premium quality MRI in a cost-sensitive environment
Introducing the new MAGNETOM Spectra Premium quality MRI in a cost-sensitive environment Integrated global set-up Simplified clinical workflow Oxford Erlangen Shenzhen: Product Ownership Globally optimized R&D and Research oriented MAGNETOM manufacturing Spectra DtC-engineering Focus on TCO reductio
Slide 24: Leading the imaging industry: summary
Leading the imaging industry Market leader in all modalities #1 in Market Share #1 in Installed Base Partner of choice in all segments #1 in Profitability Trendsetter and undisputed innovation leader Integrated global setup, driving the shift No.1 in developed Introducing high-throughput,
Slide 25: Reconciliation and Definitions for Non-GAAP Measures (I)
Reconciliation and Definitions for Non-GAAP Measures (I) To supplement Siemens’ Consolidated Financial Statements presented in accordance with International Financial Reporting Standards, or IFRS, Siemens presents the following supplemental financial measures: New orders and order backlog; Adjusted
Slide 26: Reconciliation and Definitions for Non-GAAP Measures (II)
Reconciliation and Definitions for Non-GAAP Measures (II) New orders and order backlog - continued Order backlog represents an indicator for the future revenues of our Company resulting from already recognized new orders. Order backlog is calculated by adding the new orders of the current fiscal yea
Slide 27: Reconciliation and Definitions for Non-GAAP Measures (III)
Reconciliation and Definitions for Non-GAAP Measures (III) Total Sectors Profit Siemens uses Total Sectors profit to measure the sum of profit of the four Sectors Energy, Healthcare, Industry and Infrastructure & Cities. Profit of the Sectors is earnings before financing interest, certain pension co
Slide 28: Reconciliation and Definitions for Non-GAAP Measures (IV)
Reconciliation and Definitions for Non-GAAP Measures (IV) ROCE (adjusted) – continued ROCE (adjusted) at the Siemens group level on a continuing and discontinued operations basis Siemens also presents group ROCE (adjusted) on a continuing and discontinued operations basis. For this purpose, the nume
Slide 29: Reconciliation and Definitions for Non-GAAP Measures (V)
Reconciliation and Definitions for Non-GAAP Measures (V) Adjusted EBITDA, adjusted EBIT and adjusted EBITDA margins on a continuing operations basis – continued Adjusted EBITDA margins at the Sector level Siemens defines adjusted EBITDA margins at the Sector level as the ratio of adjusted EBITDA to
Slide 30: Reconciliation and Definitions for Non-GAAP Measures (VI)
Reconciliation and Definitions for Non-GAAP Measures (VI) Limitations on the usefulness of Siemens’ supplemental financial measures The supplemental financial measures reported by Siemens may be subject to limitations as analytical tools. In particular: With respect to new orders and order backlog: